156 related articles for article (PubMed ID: 12099390)
21. Clinical, Genetic, and Protein Structural Aspects of Familial Dysalbuminemic Hyperthyroxinemia and Hypertriiodothyroninemia.
Kragh-Hansen U; Galliano M; Minchiotti L
Front Endocrinol (Lausanne); 2017; 8():297. PubMed ID: 29163366
[TBL] [Abstract][Full Text] [Related]
22. Etiology and outcome of non-estrogen associated hyperthyroxinemia in euthyroid patients at the San Juan City Hospital.
Alegre M; Meléndez EG; Colón G
Bol Asoc Med P R; 1996; 88(1-3):12-5. PubMed ID: 8885441
[TBL] [Abstract][Full Text] [Related]
23. Thyroid function tests in patients with familial dysalbuminaemic hyperthyroxinaemia (FDH).
Stewart MF; Ratcliffe WA; Roberts I
Ann Clin Biochem; 1986 Jan; 23 ( Pt 1)():59-64. PubMed ID: 3767254
[TBL] [Abstract][Full Text] [Related]
24. Free Thyroxine Concentrations in Sera of Individuals with Familial Dysalbuminemic Hyperthyroxinemia: A Comparison of Three Methods of Measurement.
Refetoff S; Scherberg NH; Yuan C; Wu W; Wu Z; McPhaul MJ
Thyroid; 2020 Jan; 30(1):37-41. PubMed ID: 31822224
[No Abstract] [Full Text] [Related]
25. A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH).
Kobayashi S; Yoshimura Noh J; Shimizu T; Sato T; Kurihara I; Sugino K; Itoh H; Ito K
Endocr J; 2017 Feb; 64(2):207-212. PubMed ID: 27904073
[TBL] [Abstract][Full Text] [Related]
26. Hepatic bioavailability of thyroxine and testosterone in familial dysalbuminemic hyperthyroxinemia.
Cefalu WT; Pardridge WM; Premachandra BN
J Clin Endocrinol Metab; 1985 Oct; 61(4):783-6. PubMed ID: 4031018
[TBL] [Abstract][Full Text] [Related]
27. Coexistence of familial dysalbuminemic hyperthyroxinemia with familial hypercholesterolemia and multiple lipoprotein type hyperlipidemia.
Premachandra BN; Wolfe B; Williams IK
Am J Med; 1988 Feb; 84(2):345-51. PubMed ID: 3407659
[TBL] [Abstract][Full Text] [Related]
28. Specific methods to identify plasma binding abnormalities in euthyroid hyperthyroxinemia.
Stockigt JR; Dyer SA; Mohr VS; White EL; Barlow JW
J Clin Endocrinol Metab; 1986 Jan; 62(1):230-3. PubMed ID: 3079602
[TBL] [Abstract][Full Text] [Related]
29. Familial Dysalbuminemic Hyperthyroxinemia (FDH), Albumin Gene Variant (R218S), and Risk of Miscarriages in Offspring.
Lai S; Gopalakrishnan G; Li J; Liu X; Chen Y; Wen Y; Zhang S; Huang B; Phornphutkul C; Liu S; Kuang J
Am J Med Sci; 2020 Nov; 360(5):566-574. PubMed ID: 32665066
[TBL] [Abstract][Full Text] [Related]
30. A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study.
Refetoff S; Marinov VS; Tunca H; Byrne MM; Sunthornthepvarakul T; Weiss RE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3335-40. PubMed ID: 8784093
[TBL] [Abstract][Full Text] [Related]
31. Can the type of variant albumin in familial dysalbuminemic hyperthyroxinemia be determined by measuring iodothyronines in serum?
Takamatsu J; Ikegami Y; Sakane S; Kitaoka H; Takeda K; Ohsawa N
Endocrinol Jpn; 1990 Jun; 37(3):389-95. PubMed ID: 2253589
[TBL] [Abstract][Full Text] [Related]
32. Thyroxin binding by human serum albumin after denaturation of the thyroxin-binding globulin in familial dysalbuminemic hyperthyroxinemia.
Arevalo G
Clin Chem; 1988 Apr; 34(4):705-8. PubMed ID: 3129213
[TBL] [Abstract][Full Text] [Related]
33. [A family with familial dysalbuminaemic hyperthyroxinaemia].
Dai WX; Liu ZY; Guo ZS; Liu ZX; Dou YL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):40-3. PubMed ID: 15696477
[TBL] [Abstract][Full Text] [Related]
34. Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Man Caused by a Point Albumin Gene Mutation (R218P).
Osaki Y; Hayashi Y; Nakagawa Y; Yoshida K; Ozaki H; Fukazawa H
Jpn Clin Med; 2016; 7():9-13. PubMed ID: 27081329
[TBL] [Abstract][Full Text] [Related]
35. Familial dysalbuminemic hyperthyroxinemia confounding management of coexistent autoimmune thyroid disease.
Khoo S; Lyons G; Solomon A; Oddy S; Halsall D; Chatterjee K; Moran C
Endocrinol Diabetes Metab Case Rep; 2020 Feb; 2020():. PubMed ID: 32101523
[TBL] [Abstract][Full Text] [Related]
36. Detection of albumin binding abnormalities in sera of patients with familial dysalbuminaemic hyperthyroxinaemia using isoelectric focusing.
Flechner I; Aranoff G; Reifen R; Landau H
Endocr Res; 1992; 18(3):229-40. PubMed ID: 1446661
[TBL] [Abstract][Full Text] [Related]
37. Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin.
Bianchi R; Iervasi G; Pilo A; Vitek F; Ferdeghini M; Cazzuola F; Giraudi G
J Clin Invest; 1987 Aug; 80(2):522-34. PubMed ID: 3112186
[TBL] [Abstract][Full Text] [Related]
38. Normal cellular uptake of thyroxine from serum of patients with familial dysalbuminemic hyperthyroxinemia or elevated thyroxine-binding globulin.
Sarne DH; Refetoff S
J Clin Endocrinol Metab; 1988 Dec; 67(6):1166-70. PubMed ID: 3142912
[TBL] [Abstract][Full Text] [Related]
39. Hyperthyroxinemia and Hypercortisolemia due to Familial Dysalbuminemia.
Moran C; Seger C; Taylor K; Oddy S; Burling K; Rajanayagam O; Fairall L; McGowan A; Lyons G; Halsall D; Gurnell M; Schwabe J; Chatterjee K; Strey C
Thyroid; 2020 Nov; 30(11):1681-1684. PubMed ID: 32669045
[TBL] [Abstract][Full Text] [Related]
40. Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia.
Petersen CE; Ha CE; Jameson DM; Bhagavan NV
J Biol Chem; 1996 Aug; 271(32):19110-7. PubMed ID: 8702585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
